Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer.
Zahra PezeshkianStefania NobiliNoshad PeyravianBahador ShojaeeHaniye NazariHiva SoleimaniHamid Asadzadeh-AghdaeiMaziar Ashrafian BonabEhsan Nazemalhosseini-MojaradEnrico MiniPublished in: Cancers (2021)
Colorectal cancer (CRC) is the third and second cancer for incidence and mortality worldwide, respectively, and is becoming prevalent in developing countries. Most CRCs derive from polyps, especially adenomatous polyps, which can gradually transform into CRC. The family of Matrix Metalloproteinases (MMPs) plays a critical role in the initiation and progression of CRC. Prominent MMPs, including MMP-1, MMP-2, MMP-7, MMP-8, MMP-9, MMP-12, MMP-13, MMP-14, and MMP-21, have been detected in CRC patients, and the expression of most of them correlates with a poor prognosis. Moreover, many studies have explored the inhibition of MMPs and targeted therapy for CRC, but there is not enough information about the role of MMPs in polyp malignancy. In this review, we discuss the role of MMPs in colorectal cancer and its pathogenesis.
Keyphrases
- poor prognosis
- cell migration
- long non coding rna
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- risk factors
- cardiovascular disease
- squamous cell carcinoma
- coronary artery disease
- drug delivery
- prognostic factors
- peritoneal dialysis
- patient reported outcomes
- chronic rhinosinusitis
- childhood cancer